(Q34327932)

English

Assessment of malignancy risk in patients with multiple sclerosis treated with intramuscular interferon beta-1a: retrospective evaluation using a health insurance claims database and postmarketing surveillance data

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Assessment of malignancy risk in patients with multiple sclerosis treated with intramuscular interferon beta-1a: retrospective evaluation using a health insurance claims database and postmarketing surveillance data (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

multiple sclerosis

0 references

author name string

Gary Bloomgren

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Bjørn Sperling

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Kimberly Cushing

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Madé Wenten

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

publication date

20 June 2012

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Therapeutics and Clinical Risk Management

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

313-321

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

copyright license

Creative Commons Attribution-NonCommercial 3.0 Unported

1 June 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

The risk of malignancy is not increased in patients with multiple sclerosis treated with subcutaneous interferon beta-la: analysis of data from clinical trial and post-marketing surveillance settings

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387830

6 July 2018

Nonexperimental comparative effectiveness research using linked healthcare databases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387830

6 July 2018

Multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387830

6 July 2018

Cancer incidence in multiple sclerosis and effects of immunomodulatory treatments.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387830

6 July 2018

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387830

6 July 2018

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387830

6 July 2018

Cancer incidence following hospitalization for multiple sclerosis in Denmark

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387830

6 July 2018

Malignant diseases among patients with multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387830

6 July 2018

Interferons and multiple sclerosis: is it plausible that beta-IFN treatment could influence the risk of cancer among MS patients?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387830

27 October 2018

Cancer in patients with motor neuron disease, multiple sclerosis and Parkinson's disease: record linkage studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387830

27 October 2018

Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387830

27 October 2018

Cancer risk among patients with multiple sclerosis: a population-based register study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387830

27 October 2018

The Danish Multiple Sclerosis Registry: a 50-year follow-up.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387830

27 October 2018

Cancer risk among patients with multiple sclerosis and their parents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387830

27 October 2018

Selective modulation of T-cell responses in autoimmunity and cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22767995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer incidence in multiple sclerosis: a 35-year follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/22767995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple sclerosis and cancer in Norway. A retrospective cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22767995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple sclerosis and risk of cancer: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22767995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer and multiple sclerosis in the era of disease-modifying treatments

1 reference

https://pubmed.ncbi.nlm.nih.gov/22767995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2147/TCRM.S31347

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34327932&oldid=1982927586"